4//SEC Filing
Elliott Mark Stuart 4
Accession 0001209191-18-014690
CIK 0001006028other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:13 PM ET
Size
10.5 KB
Accession
0001209191-18-014690
Insider Transaction Report
Form 4
Elliott Mark Stuart
Vice President, Finance
Transactions
- Disposition to Issuer
Stock Options (Right to Buy)
2018-02-26−150,000→ 0 totalExercise: $1.15Exp: 2018-05-11→ Common Stock (150,000 underlying) - Award
Stock Options (Right to Buy)
2018-02-26−150,000→ 150,000 totalExercise: $1.15Exp: 2021-05-11→ Common Stock (150,000 underlying) - Award
Stock Options (Right to Buy)
2018-02-26+150,000→ 150,000 totalExercise: $0.78Exp: 2023-02-26→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018.
- [F2]The two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 11, 2016 with an exercise period of 2 years. The term of the option has been amended to extend the exercise period to five years from the date of grant.
- [F3]25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on August 11, 2016.
Documents
Issuer
PURE BIOSCIENCE, INC.
CIK 0001006028
Entity typeother
Related Parties
1- filerCIK 0001649406
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:13 PM ET
- Size
- 10.5 KB